Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8

general

Stage IIIB includes: T4, N0-2, M0, B1. T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are

19

Centers

17

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.6
2
NCI Comprehensive
High-Volume Research Center
71.6
3
High-Volume Research Center
71.6
4
NCI Comprehensive
Active Research Program
55.0
5
NCI Comprehensive
Active Research Program
55.0
6
NCI Comprehensive
Active Research Program
55.0
7
NCI Comprehensive
Active Research Program
55.0
8
NCI Comprehensive
Active Research Program
55.0
9
NCI Comprehensive
Active Research Program
55.0
10
NCI Clinical
Active Research Program
55.0
11
Active Research Program
55.0
12
Active Research Program
55.0
13
Active Research Program
55.0
14
Active Research Program
55.0
15
NCI Comprehensive
36.1
1636.1
1736.1
18
NCI Comprehensive
36.1
19
NCI Comprehensive
36.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →